Eventide Healthcare & Life Sciences Fund

U.S. News evaluated 34 Health Funds. Our list highlights the top-rated funds for long-term investors based on the ratings of leading fund industry researchers.

See all Eventide Funds funds

See full Health rankings

See more fund rankings

Performance

The fund has returned 74.61 percent over the past year.

Trailing Returns Updated 02.28.2014
Year to date 17.8%
1 Year 74.6%
3 Years (Annualized) N/A
5 Years (Annualized) N/A
10 Years (Annualized) N/A

See more ETAHX performance

Summary

The investment seeks to provide long-term capital appreciation. Under normal market conditions, the fund will invest at least 80% of its net assets (plus borrowings for investment purposes) in equity and equity-related securities of companies in the healthcare and life sciences sectors, including common stock, options, preferred stock and convertible debt. It is non-diversified.

Fees

Fees are Low compared to funds in the same category.
Eventide Healthcare & Life Sciences Fund has an expense ratio of 1.68 percent.

See more ETAHX fees

Risk

Risk is N/A compared to funds in the same category according to Morningstar.

See more ETAHX risk

See Also:

Top Eventide Funds Funds